10-Hydroxy-2-Decenoic Acid and DHA Composition for Anxiety and Weight Management
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for anxiety, inflammatory conditions, fertility-related disorders, and cognitive performance enhancement lack effective solutions, particularly in managing weight-related issues associated with aging or stress.
Innovation Solution
Compositions comprising 10-Hydroxy-2-decenoic acid (Queen Bee Acid) combined with at least one polyunsaturated fatty acid, preferably omega-3 fatty acids like docosahexaenoic acid (DHA), administered in various forms such as free fatty acids, esters, or phospholipids, to treat anxiety, inflammatory conditions, fertility disorders, and enhance cognitive performance while managing weight.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments are used for anxiety, inflammatory conditions, and cognitive performance enhancement, then existing therapeutic approaches are applied, but they lack effective solutions and do not address weight management issues
Solution Approach 1:
The patent applies universality by creating a composition with multi-functional benefits. The combination of 10-hydroxy-2-decenoic acid and polyunsaturated fatty acids treats multiple conditions simultaneously: anxiety, inflammatory conditions, fertility-related disorders, cognitive performance enhancement, and weight management. This single composition addresses diverse therapeutic needs that conventional treatments handle separately, making the treatment approach both reliable and versatile.
2Reliability
If单一 fatty acid supplements are administered, then specific fatty acid benefits are provided, but the therapeutic effect is limited compared to combined compositions
Solution Approach 1:
The patent applies composite materials by combining 10-hydroxy-2-decenoic acid (queen bee acid) with polyunsaturated fatty acids in a single composition. This composite approach creates synergistic effects where the combination provides greater therapeutic benefit than individual components alone. The composition maintains manageable complexity while delivering enhanced reliability for treating anxiety, inflammation, and other conditions.
3Adaptability or versatility
If weight management is addressed separately from other health conditions, then weight control can be achieved, but comprehensive health improvement is limited
Solution Approach 1:
The patent resolves this contradiction by creating a universal treatment that addresses weight management alongside other health conditions. The composition of 10-hydroxy-2-decenoic acid and polyunsaturated fatty acids simultaneously manages weight, reduces anxiety, decreases inflammation, and improves cognitive function. This multi-functional approach provides comprehensive health coverage without requiring separate treatment regimens, thus maintaining simplicity while enhancing adaptability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The combination of 10-Hydroxy-2-decenoic acid and polyunsaturated fatty acids effectively treats anxiety, inflammatory conditions, and fertility-related disorders, enhances cognitive performance, and helps manage weight by reducing anxiety, inflammation, and promoting healthy weight maintenance or loss, particularly in aging or stress-related contexts.
Implementation Method 1
Queen bee acid inhibits histone deacetylases and is now recognized as the epigenetic switch for the queen bee larvae phenotype
Implementation Method 2
Other in vitro effects of queen bee acid include antitumor activity
Implementation Method 3
Izuta et al., 10-Hydroxy-2-decenoic Acid, a Major Fatty Acid from Royal Jelly Inhibits VEGF-induced Angiogenesis in Human Umbilical Vein Endothelial Cells
Implementation Method 4
stimulation of neurogenesis from stem cells while inhibiting gliogenesis
Data Source
AI summary
Disclosed herein are compositions for use in treating anxiety, inflammatory conditions, fertility-related disorders, for increasing cognitive performance and managing weight comprising 10-Hydroxy-2-decenoic acid or a derivative thereof and preferably at least one polyunsaturated fatty acid. The preferred polyunsaturated fatty acid is DHA.